{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP01206",
    "Peptide Name": "Mersacidin (natural AMPs; type-B lantibiotics, type 2, class 1 bacteriocin, Gram-positive bacteria, prokaryotes;  UCSS1b; XXT; BBW)",
    "Source": "Bacillus sp. strain HIL Y-85 54728",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "CTFTLPGGGGVCTLTSECIC",
    "Sequence Length": 20,
    "UniProt Entry": "",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Anti-MRSA"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "nonhelixbeta",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "1MQZ",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": -1,
    "Boman Index": -0.5,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "45%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Discovery: The smallest lantibiotic known to date.Chemical modification: There are 9 post-translational modifications leading to four ring structures, residues 1-2,4-12, 13-18, and 15-20. Residues 2,4,13, and 15 are Abu. The ring structure confers chemical stability and proteolysis resistance of the peptide.Activity: Active against S. aureus 209P (MIC 1.56 ug/ml), S. aureus R85 (MIC 0.78 ug/ml), S. aureus 20424 (MIC 3.12 ug/ml), S. aureus 503 (MIC 1.56 ug/ml), S. epidermidis 823 (MIC 6.25 ug/ml), S. faecalis 21777 (MIC 50 ug/ml), S. pneumoniae A77 (MIC 3.12 ug/ml), B. subtilis ATCC6633 (MIC 0.78 ug/ml) and M. luteus ATCC 9341 (MIC 0.195 ug/ml).  Active against MRSA, VRE, C. difficile.Structure:You can rotate, zoom, and view the 3D structureherein the PDB.MOA:bacteria: it targets the sugar phosphate head group of the peptidoglycan precursor lipid II and inhibits the transglycosylation of peptidoglycan biosynthesis of the cell wall. Updated 2/2014;4/2016.4/2019 CW",
    "Author": "Chatterjee S, Chatterjee S, Lad SJ, Phansalkar MS, Rupp RH, Ganguli BN, Fehlhaber HW, Kogler H.1992",
    "Reference": "J Antibiot (Tokyo). 1992 Jun;45(6):832-8",
    "Title": "Mersacidin, a new antibiotic from Bacillus. Fermentation, isolation, purification and chemical characterization."
  },
  "3D Structure": []
}